中文
Earlier issues
Announcement
More
Progress in Chemistry 2013, Vol. 25 Issue (09): 1594-1600 DOI: 10.7536/PC130720 Previous Articles   Next Articles

Chemoprevention of Oral Cancer by a Mixture of Chinese Herbs (Anti-Tumor Mixture B)

Wang Yian*1, You Ming2   

  1. 1. Department of Surgery and The Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA;
    2. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA
  • Received: Online: Published:
Richhtml ( 0 ) PDF ( 1054 ) Cited
Export

EndNote

Ris

BibTeX

Anti-tumor B (ATB) is a Chinese herbal mixture of six plants (Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus and Dioscorea bulbifera). ATB is also called Zeng Sheng Ping (ZSP). Previous studies have shown significant chemopreventive efficacy of ATB against human esophageal cancer, mostly squamous cell carcinomas. The chemopreventive effects of ATB on the development of 4-nitroquinoline-1-oxide (4NQO) induced oral squamous cell carcinomas in A/J mice were systematically evaluated and it was found that ATB reduced 4NQO-induced oral cancer development by approximately 60%. Similar results were also seen in 7,12-dimethylbenz(a)anthracene (DMBA) induced oral cancer in hamsters. A randomized clinical trial was conducted in patients with oral leukoplakia. Treatment with ATB (4 tablets, 3 times per day for 8—12 months) reduced the size of oral lesions in 68% of the patients versus 17% of the patients in the placebo control group (P < 0.01). These results indicate that ATB may be a potent chemopreventive agent against the development of oral cancer in humans.

Key words: antitumor B, Chinese herbal mixture, animal models, oral cancer, oral leukoplakia

CLC Number: 

[1] Sun Z, Guan X, Li N, Liu X, Chen X. Oral Oncol., 2010, 46: 105—110
[2] Lin P Z, Zhang J S, Cao S G, Rong Z P, Gao R Q, Han R, Shu S P. Chinese Journal of Oncology, 1988, 10: 161—166
[3] Lin P, Zhang J, Rong Z, Han R, Xu S, Gao R, Ding Z, Wang J, Feng H, Cao S. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll., 1990, 5: 121—129
[4] Lin P. Acta Academiae Medicinae Sinicae, 1990, 12: 235—245
[5] Fan X. Acta Academiae Medicinae Sinicae, 1993, 15: 71—73
[6] Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M, Lemon W L, Grubbs C J, Lubet R A, You M. Oncogene, 2004, 23: 3841—3850
[7] Wang Y, Zhang Z, Garbow J R, Rowland D J, Lubet R A, Sit D, Law F, You M. Cancer Prev. Res. (Phila), 2009, 2: 634—640
[8] Andre K, Schraub S, Mercier M, Bontemps P. Eur. J. Cancer B Oral Oncol., 1995, 31B: 301—309
[9] Iribarren C, Tekawa I S, Sidney S, Friedman G D. N. Engl. J. Med., 1999, 340: 1773—1780
[10] Murata M, Takayama K, Choi B C, Pak A W. Cancer Detect. Prev., 1996, 20: 557—565
[11] Spitz M R. Semin. Oncol., 1994, 21: 281–288
[12] Winn D M. Adv. Exp. Med. Biol., 1992, 320: 39—46
[13] Jemal A, Siegel R, Xu J, Ward E. CA Cancer J. Clin., 2010, 60(5): 277—300
[14] 周曾同(Zhou Z T). 中华口腔医学杂志(Chinese Journal of Stomatology), 2006, 41(8): 502—505
[15] Forastiere A, Koch W, Trotti A, Sidransky D. N. Engl. J. Med., 2001, 345(26): 1890—1900
[16] Steidler N E, Reade P C. Oral Surg. Oral. Med. Oral Pathol., 1984, 57: 524—531
[17] Yuan B, Heniford B W, Ackermann D M, Hawkins B L, Hendler F J. Cancer Res., 1996, 54: 5310—5317
[18] Zhang Z, Wang Y, Yao R, Lubet R A, You M. Mol. Cancer Res., 2006, 4: 401—410
[19] Wang Y, Yao R, Gao S, Wen W, Du Y, Szabo E, Hu M, Lubet R A, You M. Mol. Carcinog., 2013, 52(1): 49—56
[20] Gao G. Comparative pharmacokinetics of matrine: pure matrine vs crude chemical in ACAPHA. Doctoral Dissertation, Simon Fraser University, Burnaby, British Columbia, Canada, 2007
[21] Gao G, Law F C. Drug Metab. Dispos., 2009, 37: 884—891
[22] Christensen M E, Therkildsen M H, Hansen B L, Albeck H, Hensen G N, Bretlau P. Eur. Arch. Otorhinolaryngol., 1992, 249: 243—247
[23] Hiraishi Y, Wada T, Nakatani K, Negoro K, Fujita S. Pathol. Oncol. Res., 2006, 12: 87—91
[24] Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B. Oral Oncol., 2007, 43: 193—198
[25] Sarkis S A, Abdullah B H, Abdul M B A, Talabani N G. Head Neck Oncol., 2010, 2: 13
[26] Guan X B, Sun Z, Chen X X, Wu H R, Zhang X Y. Chin. Med. J. (Engl), 2012, 125: 332—337
[27] Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Clerici M, Formelli F, Barzan L, Carrassi A, et al. Eur. J. Cancer B, Oral Oncol., 1992, 28B: 97—102
[28] Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Formelli F, Giardini R, Costa A, De Palo G, et al. J. Cell. Biochem. Suppl., 1993, 17F: 255—261
[29] Benner S E, Winn R J, Lippman S M, Poland J, Hansen K S, Luna M A, Hong W K. J. Natl. Cancer Inst., 1993, 85: 44—47
[30] Garewal H. Eur. J. Cancer Prev., 1994, 3: 101—107
[31] Sankaranarayanan R, Mathew B, Varghese C, Sudhakaran P R, Menon V, Jayadeep A, Nair M K, Mathews C, Mahalingam T R, Balaram P, Nair P P. Oral Oncol., 1997, 33: 231—236
[32] Armstrong W B, Kennedy A R, Wan X S, Taylor T H, Nguyen Q A, Jensen J, Thompson W, Lagerberg W, Meyskens F L Jr. Clin. Cancer Res., 2000, 6: 4684—4691
[33] Halder A, Raychowdhury R, Ghosh A, De M. J. Environ. Pathol. Toxicol. Oncol., 2005, 24: 141—144
[34] Shumway B S, Kresty L A, Larsen P E, Zwick J C, Lu B, Fields H W, Mumper R J, Stoner G D, Mallery S R. Clin. Cancer Res., 2008, 14: 2421—2430
[35] Awad A B, Fink C S. J. Nutr., 2000, 130: 2127—2130
[36] Raicht R F, Cohen B I, Fazzini E, Sarwal A, Takahashi M. J. Cancer Res., 1980, 40: 403—405
[37] Awad A B, Gan Y, Fink C S. Nutr. Cancer, 2000, 36: 74—78
[38] Awad A B, Down A C, Fink C S. Int. J. Mol. Med., 2000, 5: 541—546
[39] Rao A V, Janezic S A. Nutr. Cancer, 1992, 18: 43—52
[40] von Holtz R L, Fink C S, Awad A B. Nutr. Cancer, 1998, 32: 8—12
[41] Awad A B, Downie A C, Fink C S, Kim U. Anticancer Res., 2000, 20: 821—824
[42] Awad A B, Williams H, Fink C S. Nutr. Cancer, 2001, 40: 157—164
[1] Siwang Yu, Chung S. Yang. Cancer Prevention in China：Introduction to the Special Issue on Cancer Chemoprevention [J]. Progress in Chemistry, 2013, 25(09): 1411-1414.
[2] Zeng Hongmei, Chen Wanqing. Cancer Epidemiology and Control in China：State of the Art [J]. Progress in Chemistry, 2013, 25(09): 1415-1420.
[3] Michael B. Sporn, Karen T. Liby. A Mini-Review of Chemoprevention of Cancer——Past, Present, and Future [J]. Progress in Chemistry, 2013, 25(09): 1421-1428.
[4] Barbara K. Dunn. Phase 3 Trials in Breast Cancer Prevention：Focus on Estrogen-Targeting Agents, Selective Estrogen Receptor Modulators and Aromatase Inhibitors [J]. Progress in Chemistry, 2013, 25(09): 1429-1449.
[5] Andrew T. Chan. Aspirin for the Prevention of Colorectal Cancer [J]. Progress in Chemistry, 2013, 25(09): 1450-1453.
[6] Li Junyao. Nutritional Intervention of Cancer [J]. Progress in Chemistry, 2013, 25(09): 1462-1479.
[7] Gary D. Stoner. Whole Food Approach to Cancer Prevention：Berries as an Example [J]. Progress in Chemistry, 2013, 25(09): 1480-1491.
[8] Chung S. Yang. Cancer Prevention by Vitamin E and Tea Polyphenols：Lessons Learned from Studies in Animal Models and Humans [J]. Progress in Chemistry, 2013, 25(09): 1492-1500.
[9] Ann M. Bode, Zigang Dong. Strategies for Identifying Molecular Targets for Cancer Chemoprevention [J]. Progress in Chemistry, 2013, 25(09): 1501-1516.
[10] Donghai Xiong, Raymond U. Osarogiagbon, Yian Wang, Ming You. Driver Genes as Targets for Lung Cancer Prevention and Treatment [J]. Progress in Chemistry, 2013, 25(09): 1517-1525.
[11] Zheng-Yuan Su, Limin Shu, Jong Hun Lee, Franciso Fuentes, Hu Wang, Tien-Yuan Wu, Siwang Yu, Ah-Ng Tony Kong. Perspective on Nrf2, Epigenomics and Cancer Stem Cells in Cancer Chemoprevention Using Dietary Phytochemicals and Traditional Chinese Medicines [J]. Progress in Chemistry, 2013, 25(09): 1526-1543.
[12] Wang Xiu Jun*, Li Xin, Tang Xiuwen. The Role of Nrf2 in Carcinogenesis [J]. Progress in Chemistry, 2013, 25(09): 1544-1552.
[13] Song Gao, Sumit Basu, Guangyi Yang, Arijita Deb, Ming Hu. Oral Bioavailability Challenges of Natural Products Used in Cancer Chemoprevention [J]. Progress in Chemistry, 2013, 25(09): 1553-1574.
[14] Weicheng You*, Lian Zhang, Kaifeng Pan, Junling Ma. Anti-Helicobacter pylori Infection in Gastric Cancer Prevention [J]. Progress in Chemistry, 2013, 25(09): 1575-1582.
[15] Wang Shaoming, Qiao Youlin. Vaccine and Cancer Prevention [J]. Progress in Chemistry, 2013, 25(09): 1583-1587.